fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Stocks Race Forward Weekly With Nasdaq’s Outsized Lead – $AAPL $ATOS $INVO $LCID $NVDA $TSLA Rise!

By John F. Heerdink, Jr.
Quote of the Day:  “Take chances, make mistakes. That’s how you grow. Pain nourishes your courage. You have to fail in order to practice being brave.” – Mary Tyler Moore


Happy Saturday!

I hope that you had a wonderful week and that you managed to build your wealth in the stock market and otherwise. Weather-wise in San Francisco we had a great week filled with crystal blue skies until Friday with ‘Uncle Karl’ or the fog rolled back in. Let’s hope that the San Francisco 49ers keep rolling to and win again this weekend! ‘Go Niners’!

As for the broad markets this week, investors, in general, must have seen their accounts rise as the major indices leaped forward during the current earnings season and on the back side of a new understanding that the Fed may slow their pace of interest rate hikes. The macroeconomic schedule was busy and began with Monday’s offering that included the Leading Indicators for December report that confirmed a 1% decline. On Tuesday, the preliminary January IHS Markit Manufacturing PMI came in at 46.8 & the Preliminary January IHS Markit Services PMI report came in at 46.6. On Wednesday, the Weekly MBA Mortgage Applications Index report came in at 7% & the Weekly EIA Crude Oil Inventories report came in +.533M. On Thursday, the Q4 GDP report came in at 2.9% & the Q4 Chain Deflator came in at 3.5%. The December Durable Orders report came in at 5.6%. The Weekly Initial Claims clocked in at 186K, while the weekly Continuing Claims report showed 1.675M . The December Advanced International Trade in Goods report cam in at -$90.3B. The December Advanced Retail Inventories repot was confirmed at .5%. The December Advanced Wholesale Inventories report came in at .1%. The December New Home Sales report came in at 616K. On Friday, the December Personal Income report came in at .2% & the December Personal Spending report was confirmed at -.2%. The December PCE Prices was .1%. The December Pending Home Sales report was up 2.5%. The Final January University of Michigan Consumer Sentiment 64.9. Interestingly the yield curve edged higher this week, with the 2-yr note yield moving up basis point to close at 4.21% & the 10-yr note yield moving up by 4 basis points to close at at 3.52%. he U.S. Dollar Index ticked .2% lower to close at 101.99. 

At the end of the week, the S&P 500 closed soundly over the 4k level at 4,070.56 (+2.5%) for the week and is now up 6% YTD. 9 of the 11 sectors closed in the green including the significant jumps by the consumer discretionary sector up 6.4%, the information technology sector up 4.1%, & the communication services sector up 3.3%. The laggards were the health care sector which moved down by .9% & the utilities that moved down by .5%. The 6.82% weighting of the shares of Apple (AAPL) helped the markets this week as it closed at $145.93, +5.85% over the last 5-days as the market awaits their earnings release on Feb. 2. Note that Apple’s earning for this quarter are usually their highest due to seasonal sales & a number of product launches, but reports have surfaced confirming their warnings that iPhone production was off as recently as November 2022. The shares of EV giant Tesla (TSLA) also provided significant strength this week as it closed at $177.90, +33.34% over the last 5-days and is now up 44.42% YTD. This week, Tesla released its financial results for the fourth quarter and full year ended December 31, 2022 by posting an update on its Investor Relations website. The report apparently beat the street’s expectations as Q4 Revenue rose to a record high of $24.32B vs. $24.07B (Est.) & the Q4 Adjusted EPS: $1.19 vs the $1.12 (Est.) and Elon Musk provided positive guidance. Elon Musk also is reportedly looking at using up to $3B in new fundraising to ‘offset’ the cost of the Twitter acquisition. 

The Dow 30 closed also moved nicely higher closing at 33,978.00 (+1.8%) and is now up +2.5% YTD despite a poor showing by Chevron (CVX) that dropped 4.44% on Friday after missing Wall Street’s expectations. The Walt Disney Company (DIS) closed at $109.54, up +5.86% over the last 5-days. Recently, Jim Cramer called on Disney to elect activist investor Nelson Peltz to its board and stated, “Someone like Peltz, who’s been tremendously successful, wants to join them and they act like that’s a problem.”

The Nasdaq clocked in another impressive win ending the week at 11,621.70 (+4.3%) for the week and is up 11% YTD. On Friday, shares of Newark, CA-based Lucid Motors (LCID), a luxury electric vehicle company, flew up as high as 88% on Friday and closed at $12.87, +43% after trading a whopping 204,292,144 shares volume. The stock was halted many times as investors were apparently operating under the belief that Saudi Arabia’s Public Investment Fund (PIF) may be considering purchasing the balance of the shares that they do not control & shorts were trying to cover along the way.

As the small caps on the Russell 2000 closed at 1,911.46 (2.4%) for the week, but is still up a solid +8.5% YTD. The MicroCaps also made it to the green as the iShares Micro-Cap ETF (IWC) closed at $117.08 up 1.46% this week, & is now up 8.58% YTD.  

Biotech stocks also rose across the board this week. On the larger side of things, the Nasdaq Biotechnology ETF (IBB) moved up and closed at $137.23, +1.30% and is up 4.52% YTD, the NYSE ARCA Biotech Index (^BTK) closed at 5,591.90, +1.15% over the last 5-days and is now up 5.89% YTD, & the SPDR S&P Biotech ETF (XBI) closed at $89.39, up 2.76% over the last 5-days & is now up 7.70% YTD. The 52-week range is is now $61.78-$99.16. The iShares U.S. Healthcare ETF (IYH) closed at $278.79, -.73% over the last 5-days and is now down 1.73% YTD. 

With the overall positive market swing in the broad markets, the CBOE Volatility Index (^VIX) and volatility lovers lost significantly as it closed at $18.51, down 6.75% over the last 5-days and is now down 14.58% YTD.

FURTHER AFIELD 

Shares of JPMorgan (JPM) closed at $14032, +3.88% over the last 5-days. On Jan. 20, J.P. Morgan Asset Management (JPMAM) announced significant steps in advancing its long-standing commitment to expanding in China. JPMAM has received regulatory approval from the China Securities Regulatory Commission (CSRC) to complete its acquisition of China International Fund Management Co., Ltd. (CIFM). CIFM will be operating under the JPMAM brand in China (JPMAM China), reflecting its integration into the firm’s global operating model.

On  January 13, JP Morgan reported its Q4 results. Jamie Dimon, Chairman and CEO, commented on the financial results: “JPMorgan Chase reported strong results in the fourth quarter as we earned $11.0 billion in net income, $34.5 billion in revenue and an ROTCE of 20%, while maintaining a fortress balance sheet and making all necessary investments. This robust earnings generation combined with the execution of our capital strategy allowed us to exceed our CET1 target of 13% one quarter early, and we have the ability to resume stock buybacks this quarter, as we deem appropriate. Looking further ahead, we still await details of the Basel III finalization package, but we will manage to the new requirements as we have demonstrated in the past.Our lines of business performed well in the quarter, and we continued to see momentum in our areas of strategic focus. In Consumer & Community Banking, debit and credit card sales were up 9%, while card loans were up 19% with total revolving balances now back to pre-pandemic levels. In the Corporate & Investment Bank, Markets revenue rose 7% as client activity remained strong in Fixed Income. Global Investment Banking fees were down significantly in a challenging environment, although we maintained our #1 ranking in 2022. Commercial Banking loans were up 14% on new loan originations and higher revolver utilization. And in Asset & Wealth Management, revenue increased 3% as higher net interest income more than offset the impact of lower market levels. The U.S. economy currently remains strong with consumers still spending excess cash and businesses healthy. However, we still do not know the ultimate effect of the headwinds coming from geopolitical tensions including the war in Ukraine, the vulnerable state of energy and food supplies, persistent inflation that is eroding purchasing power and has pushed interest rates higher, and the unprecedented quantitative tightening. We remain vigilant and are prepared for whatever happens, so we can serve our customers, clients and communities around the world across a broad range of economic environments. As a result of the investments we have made over the years and our dedication to clients, the Firm is in a position of strength as the market leader in U.S. retail deposits, credit cards, business banking, Payments, Markets, investment banking and multifamily lending as some examples. But we will not rest here, and we remain committed to investing in the franchise and innovating. The importance of these investments and investing through cycles was particularly evident this year, as we generated a robust ROTCE of 18% even after sharply accelerating our investments in the business. In 2022, we extended credit and raised $2.4 trillion in capital for small and large businesses, governments and U.S. consumers. Finally, I want to reiterate how proud I am of our employees and how they work to support our customers and communities and earn their trust every single day.”


Shares of Amazon.com, Inc. (AMZN) closed $102.24, +5.13% over the last 5-days.

On Jan. 24, Amazon announced RxPass, a new Prime membership benefit from Amazon Pharmacy that offers patients affordable access to commonly prescribed generic medications that treat more than 80 common health conditions. With RxPass, Prime members can receive all of their eligible medications for one flat, low monthly fee of $5, and have them delivered free of charge. There are no hidden fees and no markups to the $5 per month subscription. RxPass is available starting today in most U.S. states.

Amazon.com will hold a conference call to discuss its fourth quarter 2022 financial results on Thursday, February 2, 2023, at 2:30 p.m. PT/5:30 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir.


Shares of Microsoft Corp. (MSFT) closed at $248.16, +3.31% over the last 5-days.  This week. Microsoft reported their FY23 Q2 beating expectations, but offered somewhat sour guidance as their CEO, Satya Nadella/management kept using the word ‘caution’ or ‘cautious’ during their call. Note that Microsoft forecasted Q3 revenue their ‘intelligent cloud business’ below market previous estimates now offering a growth rate of 19%.

Shares of Salesforce, Inc. (CRM) closed at $164.52, +8.77% over the last five days. Currently under the microscope of the activist fund Elliott Capital, on Jan. 27, Salesforce announced, as part of its ongoing board refreshment process, the following appointments to the Company’s Board of Directors, effective March 1, 2023: Arnold Donald, former President and Chief Executive Officer of Carnival Corporation & plc; Sachin Mehra, Chief Financial Officer of Mastercard; and Mason Morfit, Chief Executive Officer and Chief Investment Officer of ValueAct Capital.

Shares of Intel (INTC), which fell as much as 3.63% over the last 5-days. Intel missed quarterly expectations as adjusted earnings/share came in at $.10 against the $.19 expected. Revenue totaled $14.04B and just below the expected $14.5B. They offered “economic and market headwinds and short term challenges’ for their outlook. 

Shares of NVIDIA (NVDA), a pioneer in accelerated computing, closed at $203.65, +14.16% over the last 5-days. Recently, NVIDIA and Hon Hai Technology Group (Foxconn), the world’s largest technology manufacturer, announced a strategic partnership to develop automated and autonomous vehicle platforms.

Cathie Wood’s ARK Innovation ETF (ARKK) closed at $40.39, +10.66% over the last 5-days. Note that Cathie Wood’s Ark funds hadreportedly grabbed 806,663 Tesla shares in January, which again is up 33.34%. 

The Technology Select Sector SPDR Fund (XLK) closed at $136.70, +4.08% over the last 5-days. 

Shares of McDonald’s (MCD) closed at $272.46,+1.44% over the last 5-days. McDonald’s Corp stated earlier in January that review its corporate staffing levels & will aim to build more restaurants.

GOLD & SILVER

Gold prices closed at $1932/oz., +$2/oz. & silver prices closed at $23.64/oz., -$.34/oz. for the week.

Hecla Mining (HL) closed at $6.24, -.32% over the last 5-days after announcing last week that they have realized a 10% increase in silver production over 2021 & that Keno Hill is expected to produce more than 2.5 million ounces in 2023.  First Majestic (AG) closed at $7.96, -1.24% over the last 5-days. On Jan. 19, First Majestic announced that total production in the fourth quarter of 2022 from the Company’s four producing operations, the San Dimas Silver/Gold Mine, the Jerritt Canyon Gold Mine, the Santa Elena Silver/Gold Mine and the La Encantada Silver Mine reached 7.6 million silver equivalent (“AgEq”) ounces, consisting of 2.4 million silver ounces and 63,039 gold ounces. Total production for the full year of 2022 reached a new Company record of 31.3 million AgEq ounces, consisting of 10.5 million silver ounces and 248,394 gold ounces, or a 16% increase compared to 2021. In 2023, the Company is expecting to increase production to a new Company record of between 33.2 to 37.1 million AgEq ounces, consisting of 10.0 to 11.1 million ounces of silver and 277,000 to 310,000 ounces of gold, with an all-in sustaining cost (“AISC”) guidance of between $18.47 to $19.72 per AgEq ounce. Based on the midpoint of the guidance range the Company expects AgEq ounces to increase 12% when compared to 2022.


MEMES CENTRAL

AMC Entertainment (AMC) closed at $5.51, -.18% & (APE) closed at $1.92, +10.34% over the last 5-days.   

GameStop (GME) closed at $22.82, +16.37% over the last 5-days as the shorts won overall this week. 

Seanergy Maritime Holdings Corp. (SHIP) closed at $.5677, -8.44% over the last 5-days. On Jan. 20, Seanergy announced an aggregate of $8.8 million of buybacks of its securities consisting of:

(i) $8 million of its outstanding convertible note with 5.5% coupon and a conversion price of $1.20 per share (the “Note”), pursuant to the terms of the Note, and

(ii) $0.8 million in 4,038,114 warrants at $0.2 per warrant, pursuant to the recently completed tender offer. The repurchased securities represent approximately 47% of the outstanding Class E Warrants to purchase an equal number of shares at an exercise price of $0.524 per share.

Moreover, Seanergy’s Chairman & CEO, Stamatis Tsantanis, has since August 2022 purchased 300,000 of the Company’s common shares in the open market.



CRYPTO & BITCOIN

Bitcoin (BTC) closed at $23,079.04, +.63% over the last 5-days at the time this report was prepared. 

ENERGY

The Energy Select Sector SPDR Fund or ETF (XLE) closed at $91.43, +.83% over the last 5-days. 

Chevron (CVX) closed at $179.45, -.80% over the last 5-days. On Jan. 27, Chevron reported earnings of $6.4 billion ($3.33 per share – diluted) for fourth quarter 2022, compared with $5.1 billion ($2.63 per share – diluted) in fourth quarter 2021. Included in the current quarter were $1.1 billion of international upstream write-off and impairment charges, and pension settlement costs of $17 million. Foreign currency effects decreased earnings by $405 million. Adjusted earnings of $7.9 billion ($4.09 per share – diluted) in fourth quarter 2022 compared to adjusted earnings of $4.9 billion ($2.56 per share – diluted) in fourth quarter 2021. Chevron reported full-year 2022 earnings of $35.5 billion ($18.28 per share – diluted), compared with $15.6 billion ($8.14 per share – diluted) in 2021. Adjusted earnings of $36.5 billion ($18.83 per share – diluted) in 2022 compared to adjusted earnings of $15.6 billion ($8.13 per share – diluted) in 2021. For a reconciliation of adjusted earnings, see Attachment 6. Sales and other operating revenues in fourth quarter 2022 were $55 billion, compared to $46 billion in the year-ago period.

Warren Buffet’s pick in the sector, Occidental Petroleum (OXY) closed at $66.54, -.55% over the last 5-days. Occidental will announce its fourth quarter 2022 financial results after close of market on Monday, February 27, 2023, and will hold a conference call to discuss results on Tuesday, February 28, 2023, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10173524/f531c7c588.

Oil prices closed on Friday to end at $79.46/bbl and down 2.7% over the last 5-days and is down 1% YTD.

NEXT WEEK



The markets will be back up and running for 5 full trading sessions in the stock market again next week. We will receive the FOMC interest rate decision will be at the end of the January 31- Feb. 1 meeting. The earnings season will also roll on with reports from headliners such as Alphabet (GOOG), Amazon.com (AMZN), Apple (AAPL) , &  Meta Platforms (META)

VP WATCHLIST UPDATES

Please review a select group of emerging names below and their updates below:

 
 
 
Shares of ADT Inc. (ADT), the most trusted brand in smart home and small business security, closed at $8.60, -2.05% over the last 5-days, after establishing a new 52-wk high at $10.10 recently. On Jan. 9, ADT announced the appointment of Wayne Thorsen to the newly created role of Executive Vice President and Chief Business Officer, effective immediately. Thorsen will be responsible for leading ADT’s product, innovation and new business development teams. “Wayne is a seasoned executive who brings valuable experience in business development, strategic partnerships and product marketing and development,” said Jim DeVries, ADT President and CEO. “Wayne’s expertise will accelerate our strategy to sustainably grow our business and continue to attract strategic partners by showcasing ADT’s market leadership.”
 
On Oct. 13, ADT, announced that it has issued and sold in a private placement to State Farm 133.3 million shares of ADT common stock for a gross purchase price of $1.2 billion. In September, ADT announced a new partnership with State Farm to revolutionize the homeownership experience through innovation in the detection and mitigation of property losses. In addition to the equity investment, State Farm has committed up to $300 million to fund product and technology innovation, customer growth and marketing activities in connection with the partnership. State Farm has funded the first $100 million and the two companies will collaborate to approve initiatives utilizing the funds.
 
 
 
  • Shares of Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology, with a current focus on breast cancer and radiation-induced lung injury, closed at $.82, up +1.23% over the last 5-days and now up a whopping 54.72% YTD. 
    • On Wednesday Jan. 25, Atossa Therapeutics announced the issuance of the following Letter to Shareholders from Steven C. Quay, M.D., Ph.D., the Company’s CEO and Chairman:

      TO OUR VALUED STOCKHOLDERS:

      2022 was a year of significant progress for Atossa. We focused our development efforts on advancing our breast cancer program with our patented (Z)-endoxifen, the highest potency Selective Estrogen Receptor Modifier (SERM). We currently have Phase 2 studies ongoing in the prevention and treatment settings, both focused on areas of unmet medical need. Our goal is to both help reduce the incidence of breast cancer and change the treatment paradigm for patients who are not benefiting from currently approved drugs.

      In October 2022, the U.S. Food and Drug Administration (FDA) authorized the initiation of our EVANGELINE study, a Phase 2 trial of (Z)-endoxifen and Exemestane + Goserelin as neoadjuvant treatment in premenopausal women with ER+/HER2- breast cancer. While there are several FDA-approved neoadjuvant therapies for ER- breast cancers, few exist for the ER+ patients, which account for approximately 78% of breast cancers. We expect to enroll approximately 175 patients at up to 25 sites across the United States.  READ THE BALANCE OF THE PROGRESS REPORT BY CLICKING HERE.

    • Jason McCarthy Ph.D., a biotech analyst at the Maxim Group, put out a note on July 28th reconfirming his BUY rating and a $4 target price on Atossa.
  •  

  • The multi-billion-dollar global fertility market is predicted to reach approximately US$47.9 billion by 2030, yet remains severely underserved with many patients (upwards of 90% by many estimates) unable to access affordable treatment. INVO Bioscience, Inc. (NASDAQ: INVO) offers the INVOcell solution which provides an advanced, effective and affordable infertility treatment to help increase access to care. INVO is commercially advancing INVOcell through the opening of INVO Centers, opportunistically now pursuing acquisitions of established fertility (IVF) clinics in the U.S., and continuing to offer the technology to existing fertility practices.  Shares INVO closed at $.6076 and is up +26.58%over the last 5-days and is up 43.30% YTD.  The 52-wk range is $.3290 – $3.60.
  • On Jan. 5, INVO Bioscience announced it has entered an exclusive distribution agreement with Ming Mei Technology Co. Ltd (“Ming Mei”) for Taiwan. The agreement will have an initial 1-year term with renewals. Ming Mei is a leading distributor of fertility-based devices and components in Taiwan helping to bring the latest and most advanced medical equipment into the region. Ming Mei estimates it has approximately 90% coverage of reagents and consumables in the reproductive medicine market in Taiwan. With strong customer relationships in the region, and their familiarity with the field of reproductive medicine, Ming Mei is ideally suited to expand distribution of INVOcell in Taiwan. Taiwan is a destination for assisted reproductive technology (ART) throughout Asia and also has the lowest birthrate in the world. Taiwan’s birth rate has dropped as a result of similar trends elsewhere in Asia, such as later marriage and increasing cost of living. Further, the average age of patients requiring therapy is rising. Fortunately, according to the statistics published by “ICMART”, the overall implantation rate of therapy in Taiwan ranked second worldwide, almost equal to the level in the U.S., and a leading country in Asia. The stable high success rate derives from updated medical research and enriched clinical experience from the physicians, advanced laboratory facilities and technology as well as patient-centered customized treatment plans (depending on their age, ovarian functions and causes of infertility, etc.). Prior to the pandemic, in 2019 there were approximately 55,000 ART cases in Taiwan, an increase of approximately 55% compared to 2016. In July 2021, the government in Taiwan implemented a subsidy plan for ART with the goal of encouraging more local married couples to undergo ART treatments. The subsidies are also available to transnational couples in which one spouse holds a Taiwanese ID card.



    • On Nov. 30, INVO announced the birth of the first baby in Malaysia utilizing the INVOcell solution. The healthy baby boy weighed 3.53 kg and was born on November 11, 2022 at Tuanku Mizan Military Hospital in Kuala Lumpur. Physicians at Advanced Reproductive Centre (ARC), at Hospital Canselor Tuanku Muhriz (HCTM), at the National University of Malaysia conducted the IVC procedure. The patient was part of a prospective peer reviewed study of INVOcell compared to conventional IVF (“cIVF”) that took place at ARC at HCTM. The study, titled “Comparison of Treatment Outcomes among Sibling Oocytes Using Different Culture Systems—Conventional IVF versus INVOcell Device—And Evaluation of INVOcell User Satisfaction: The INVOcIVF Study,” was published in the International Journal of Environmental Research and Public Health. “We couldn’t be more pleased to have been a part of this family’s journey towards parenthood,” commented Steve Shum, CEO of INVO Bioscience. “The INVOcell solution is playing a key role in providing families across the world an alternative method to parenthood by leveraging its innovative medical device to allow fertilization and early embryo development to take place in vivo within the woman’s body; an approach that provides for affordable, high-quality, patient-centered fertility care.” Key findings of the study included:

      • The fertilization rate and good embryo quality were comparable (not significantly different) between INVOcell and cIVF.
      • Although both methods produce similar fertilization rates and good-quality embryos, the blastulation rates were better in the INVOcell group.
      • INVOcell can be used as an alternative method for reproductive treatment in carefully selected patients without jeopardizing outcomes.
      • cIVF is costly and not applicable in most rural and district areas, therefore, the INVOcell can be utilized as a cost-effective alternative to cIVF without sacrificing comfort and outcomes.


    • On Nov. 10, Chinook provided a business update and reported financial results for the quarter and nine months ended September 30, 2022. “During the third quarter of 2022, we continued advancing our pipeline of clinical and preclinical programs for rare, severe chronic kidney diseases. We are pleased with the strong data presented at ASN Kidney Weekend 2022 from both our lead programs, atrasentan and BION-1301, in IgA nephropathy (IgAN), as well as from CHK-336 and our preclinical research approach,” said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. “We look forward to 2023, when we plan to initiate a phase 3 study of BION-1301 in patients with IgAN, present data from the ongoing phase 1 clinical trial of CHK-336 in healthy volunteers in the first half and report topline proteinuria data from the ongoing phase 3 ALIGN study of atrasentan in the third quarter.”



  • Borqs Technologies, Inc. (Nasdaq: BRQS, $.299, down 6.56% over the last 5-days, but is up a cool 43.75% YTD), a global provider of 5G wireless solutions, Internet of Things (IoT) solutions, and innovative clean energy, recently provided the following updates on the Company.
  • On Dec. 19, Borqs announced the Company has received a letter dated December 13, 2022 (the “Letter”) from the Department of the Treasury on behalf of the Committee on Foreign Investment in the United States (“CFIUS”) stating that the Company is required to negotiate with CFIUS to fully divest its ownership interests and rights in Holu Hou Energy LLC (“HHE”) due to HHE solar energy storage system and EnergyShare technology for Multi-Dwelling Residential Units (“MDU’s”) being deemed a critical technology and therefore a potential national security risk. As stated in the Letter, HHE is considered a top ten solar energy storage supplier in Hawaii, has only been increasing its dominant market share, expects to grow at an exponential rate, and focuses on multi-family dwelling units which are common in military housing. Due to Borqs’ IoT software development and hardware sourcing capabilities in China, CFIUS is concerned that through Borqs, the PRC could gain significant visibility and exert influence over HHE’s business operations and get access to HHE critical technology. CFIUS is requiring the Company to design a plan to mitigate all identified national security risks to the satisfaction of CFIUS. Borqs intends to comply to the requirements from CFIUS and enter into a National Security Agreement with various departments of the U.S. Government with a plan that is effective, monitorable and verifiable to voluntarily divest Borqs’ investment interests and rights in HHE (the “Plan”). HHE’s commercialization of its solar energy storage system and novel EnergyShare technology for MDU’s has enabled the company to open up a new market segment for renewable energy in the USA – likely worth several billions of dollars. In the last year the Company’s MDU development pipeline has reached thousands of individual units in Hawaii alone, with California MDU potential being at least one to two orders of magnitude higher in the coming years. One segment of this new market is for communities of military and other government personnel. The overall MDU opportunity is significant for the company and significant for the USA. Since Borqs’ financial support in HHE starting from October 2021, HHE has signed approximately $50 million in contracts and has a growing pipeline approaching half a billion dollars. We believe this voluntary mitigation will enable the tremendous inherent value of HHE to be realized and that the divestment can be a profitable transaction for Borqs’ shareholders. The Plan to mitigate will include engaging a nationally recognized investment bank with experience in administering competitive sales and auction processes, assigning and hiring of security and monitoring personnel to directly communicate with CFIUS, immediate and complete removal of all Borqs administrative and technical influence over HHE, immediate voluntary reduction of Borqs ownership of HHE from a majority to a minority position and with the target of divesting all. The Company believes such points will enable the Company to accomplish the divestment in an orderly manner.

  • On Dec.8, Borqs announced its subsidiary, Holu Hou Energy (HHE), has received multiple purchase orders for its HoluPower xP solar energy storage systems for installation at homeowner locations in the Greater San Diego area in California. These orders represent the first for the Company in California. Whereas in Hawaii HHE works to develop and construct Single-Family Residential projects as an “end to end” provider, the Company will target the California homeowner market through already existing channel partners that will sell and construct the projects. For Multi-Dwelling Unit (MDU) Residential properties in the State, the Company will initially target apartment owners, REITs and other MDU stakeholders directly, then partner with existing licensed contractors for system construction. HHE has been focused on the Hawaii market since it began commercial shipments in 2020, in order to become successfully established in the largest market in the United States based upon solar installation penetration. Now it is turning to California, the largest market in terms of size of available opportunity. HHE recently completed the testing and documentation required for the HoluPower xP to be listed as an approved product by the California Energy Commission. The Company expects to be listed by early January 2023, after which permitting and installations can commence. In Hawaii, Holu Hou Energy has quickly become a leader for solar energy storage systems in the Single-Family Residential market, and has essentially created the previously untapped Multi-Dwelling Unit (“MDU”) Residential market for renewable energy by virtue of its “EnergyShare” technology. The same leading product attributes will benefit MDU property owners and homeowners in California. The potential available MDU market in California is believed to be in the billions of dollars. EnergyShare enables networked systems to share excess generation behind their respective utility meters, a game-changer for improving the project economics for the MDU market, including for low-income housing, rental property units and Home Owners Association managed condominiums and town homes. EnergyShare enables more energy to be delivered to load, and fewer batteries to be installed than the standard approach of a unit-by-unit installation.
  •  
  • On Dec. 8, Borqs announced its subsidiary, Holu Hou Energy (HHE), has received multiple purchase orders for its HoluPower xP solar energy storage systems for installation at homeowner locations in the Greater San Diego area in California. These orders represent the first for the Company in California. Whereas in Hawaii HHE works to develop and construct Single-Family Residential projects as an “end to end” provider, the Company will target the California homeowner market through already existing channel partners that will sell and construct the projects. For Multi-Dwelling Unit (MDU) Residential properties in the State, the Company will initially target apartment owners, REITs and other MDU stakeholders directly, then partner with existing licensed contractors for system construction. HHE has been focused on the Hawaii market since it began commercial shipments in 2020, in order to become successfully established in the largest market in the United States based upon solar installation penetration. Now it is turning to California, the largest market in terms of size of available opportunity. HHE recently completed the testing and documentation required for the HoluPower xP to be listed as an approved product by the California Energy Commission. The Company expects to be listed by early January 2023, after which permitting and installations can commence. In Hawaii, Holu Hou Energy has quickly become a leader for solar energy storage systems in the Single-Family Residential market, and has essentially created the previously untapped Multi-Dwelling Unit (“MDU”) Residential market for renewable energy by virtue of its “EnergyShare” technology. The same leading product attributes will benefit MDU property owners and homeowners in California. The potential available MDU market in California is believed to be in the billions of dollars. EnergyShare enables networked systems to share excess generation behind their respective utility meters, a game-changer for improving the project economics for the MDU market, including for low-income housing, rental property units and Home Owners Association managed condominiums and town homes. EnergyShare enables more energy to be delivered to load, and fewer batteries to be installed than the standard approach of a unit-by-unit installation.



Shares of InMed Pharmaceuticals Inc. (INM), a leader in the research, development and manufacturing of rare cannabinoids, closed at $1.80.

  • On Jan. 10. InMed issued a press release that outlined their key accomplishments from 2022 and provided business update and catalysts for 2023 including the following interesting milestones for 2023: Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023, Progress preclinical research in glaucoma in preparation for human trials, & Advance research using rare cannabinoids in treating neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. Please read our latest PROGRESS REPORT by clicking here.

  • On Dec. 16, InMed confirmed that, at its annual general meeting of shareholders held on December 15, 2022 (the “Meeting”), all of the matters put forward before shareholders for consideration and approval as set out in InMed’s notice of meeting and management information circular, dated October 28, 2022, were approved by the shareholders. In particular, shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. See results. 
  • On Dec. 12, InMed announced the Company has entered into a service contract with Brio Financial Group to provide senior financial leadership and bookkeeping services. Pursuant to the Contract, Mr. Jonathan Tegge, a member of Brio, will assume the role of Interim Chief Financial Officer for the Company effective December 12, 2022. Brio is a financial and management consulting group based in Bridgewater, New Jersey. The firm provides outsourced financial management and financial reporting support to small and middle market entities. Currently, the team provides consulting services to over 50 private and publicly traded companies. Additionally, the Company announces that its auditor, KPMG, has resigned effective as of December 8, 2022, and that the Audit Committee of the Board of Directors of the Company approved the engagement of Marcum LLP  as its auditor, subject to Marcum’s completion of their client acceptance procedures. Marcum will stand for appointment at the Company’s Annual General Meeting, currently scheduled for Thursday, December 15, 2022. KPMG has confirmed that there are no reportable events (as such term is defined in National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”)).




Cellectis (CLLS, $3.10, +1.31% over last 5-days and is now up 47.62% YTD), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced Friday, Jan. 20 that it has amended certain financial terms of the $20 million convertible note issued by its partner, Cytovia Therapeutics, LLC  in payment of the upfront collaboration consideration provided for pursuant to the research collaboration and non-exclusive license agreement between Cellectis and Cytovia. The amended and restated note provides for automatic conversion into common stock of Cytovia in the case of certain fundamental transactions pursuant to which Cytovia becomes a public reporting company and for conversion at Cellectis’ option in connection with certain financing transactions, upon a company sale and at final maturity. In each case such conversion is subject to a 9.9% ownership cap, with the balance issuable in the form of pre-funded warrants. Among other changes, the amended and restated note increased the applicable interest rate of the note to 10% per annum, subject to a 10% step up upon the occurrence and continuation of an event of default, provided for the repayment of 50% of the outstanding amount on April 30, 2023 and extended the final maturity date for the repayment of the remaining outstanding amount to June 30, 2023. 


Cytovia Therapeutics aims to accelerate patient access to transformational cell therapies and immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on harnessing the innate immune system by developing complementary and disruptive iPSC-derived Natural Killer (iNK) cell and Flex-NK™ bispecific antibody platforms. The company is developing three types of iNK cells: unedited iNK cells, TALEN® gene-edited iNK cells with improved function and persistence, and TALEN® gene-edited iNK cells with chimeric antigen receptors (CAR-iNKs) to improve tumor-specific targeting. The second complementary cornerstone technology is a quadrivalent multifunctional antibody platform designed to engage natural killer cells by targeting NKp46 using Cytovia’s proprietary Flex-NK™ technology. These two technology platforms are being used to develop treatment for patients with solid tumors such as HCC and glioblastoma as well as hematological malignancies such as refractory multiple myeloma. Headquartered in Aventura, FL., Cytovia has research and development laboratories in Natick, MA. The company’s own R&D work is augmented through scientific partnerships with Cellectis, CytoImmune, the Hebrew University of Jerusalem, INSERM, the New York Stem Cell Foundation, the National Cancer Institute, and the University of California San Francisco (UCSF). Cytovia has a partnership with CytoLynx Therapeutics focused on research and development, manufacturing, and commercialization activities in Greater China.


Thanks again for your attention this week. Please continue to share your thoughts, questions, & ideas as we move forward. 

In the meantime, please enjoy the balance of the weekly newsletter’s videos, quotes, updates and let’s find ways to crush it again this year!

Investing & Inspiration

  1. “Take chances, make mistakes. That’s how you grow. Pain nourishes your courage. You have to fail in order to practice being brave.” – Mary Tyler Moore
  2. “A single twig breaks, but the bundle of twigs is strong.” – Tecumseh
  3. “If one does not know to which port one is sailing, no wind is favorable.” – Lucius Annaeus Seneca
  4. “There is little that can withstand a man who can conquer himself.” – Louis XIV
  5. “The limits of the possible can only be defined by going beyond them into the impossible.” – Arthur C. Clarke
  6. “Be faithful in small things because it is in them that your strength lies.” – Mother Teresa
  7. “The future rewards those who press on. I don’t have time to feel sorry for myself. I don’t have time to complain. I’m going to press on.” – Barack Obama
  8. “By three methods we may learn wisdom: First, by reflection, which is noblest; Second, by imitation, which is easiest; and third by experience, which is the bitterest.” – Confucius
  9. “No man was ever wise by chance.” – Lucius Annaeus Seneca
  10. “Progress is man’s ability to complicate simplicity.” – Thor Heyerdahl
  11. “It is not in the stars to hold our destiny but in ourselves.” – William Shakespeare
  12. “It does not matter how slowly you go as long as you do not stop.” – Confucius

  13. “I want to put a ding in the universe.” – Steve Jobs

  14. “Research is creating new knowledge.” – Neil Armstrong

  15. “The reward for work well done is the opportunity to do more.” – Jonas Salk
  16. “Man is a creative retrospection of nature upon itself.” – Karl Wilhelm Friedrich Schlegel
  17. “There’s something about taking a plow and breaking new ground. It gives you energy.” – Ken Kesey
  18. “Success seems to be largely a matter of hanging on after others have let go.” – William Feather

  19. “The essential conditions of everything you do must be choice, love, passion.” – Nadia Boulanger
  20. “More business is lost every year through neglect than through any other cause.” – Rose Kennedy

  21. “Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.” – Archimedes

  22. “A person who won’t read has no advantage over one who can’t read.” – Mark Twain
  23. “The best way out is always through.” – Robert Frost

  24. “Start by doing what’s necessary; then do what’s possible; and suddenly you are doing the impossible.” – Francis of Assisi
  25. “Without labor nothing prospers.” – Sophocles

  26. “Intellectuals solve problems, geniuses prevent them.” – Albert Einstein
  27. “This is the precept by which I have lived: Prepare for the worst; expect the best; and take what comes.” – Hannah Arendt

  28. “The best and most beautiful things in the world cannot be seen or even touched – they must be felt with the heart.” – Helen Keller

  29. “He who is brave is free.” – Lucius Annaeus Seneca
  30. “When something is important enough, you do it even if the odds are not in your favor.” – Elon Musk

  31. “I choose a block of marble and chop off whatever I don’t need.” – Auguste Rodin

  32. “Hope is the only bee that makes honey without flowers.” – Robert Green Ingersoll

  33. “He who knows that enough is enough will always have enough.” – Lao Tzu

  34. “Plans to protect air and water, wilderness and wildlife are in fact plans to protect man.” – Stewart Udall
  35. “In order to carry a positive action we must develop here a positive vision.” – Dalai Lama

  36. “A hero is someone who understands the responsibility that comes with his freedom.” – Bob Dylan
  37. “Inflation destroys savings, impedes planning, and discourages investment. That means less productivity and a lower standard of living.” – Kevin Brady
  38. “If we give something positive to others, it will return to us. If we give negative, that negativity will be returned.” – Allu Arjun
  39. “A good plan violently executed now is better than a perfect plan executed next week.” ~ George S. Patton
  40. “You must do the things you think you cannot do.”- Eleanor Roosevelt
  41. “Success is dependent on effort.” – Sophocles
  42. “Nobody who ever gave his best regretted it.” – George Halas
  43. “Lots of people want to ride with you in the limo, but what you want is someone who will take the bus with you when the limo breaks down.” ~ Oprah Winfrey
  44. “And when I breathed, my breath was lightning.” – Black Elk
  45. “Moderation is the silken string running through the pearl chain of all virtues.” – Joseph Hall
  46. “You are the sum total of everything you’ve ever seen, heard, eaten, smelled, been told, forgot – it’s all there. Everything influences each of us, and because of that I try to make sure that my experiences are positive.” – Maya Angelou
  47. “If you want a guarantee, buy a toaster.” – Clint Eastwood
  48. “We are an impossibility in an impossible universe.” – Ray Bradbury
  49. “If you think in terms of a year, plant a seed; if in terms of ten years, plant trees; if in terms of 100 years, teach the people.” – Confucius
  50. “I’d rather attempt to do something great and fail than to attempt to do nothing and succeed.” – Robert H. Schuller
  51. Do your little bit of good where you are; it’s those little bits of good put together that overwhelm the world.” Desmond Tutu
  52. “It takes considerable knowledge just to realize the extent of your own ignorance.” – Thomas Sowell
  53. “Do not dwell in the past, do not dream of the future, concentrate the mind on the present moment.” – Buddha”
  54. Surprise is the greatest gift which life can grant us.” –  Boris Pasternak
  55. “Trust in dreams, for in them is hidden the gate to eternity.” – Khalil Gibran 
  56. “Always be yourself, express yourself, have faith in yourself, do not go out and look for a successful personality and duplicate it.” – Bruce Lee
  57. “All life is an experiment. The more experiments you make the better.” – Ralph Waldo Emerson
  58. “There are no secrets to success. It is the result of preparation, hard work, and learning from failure.” –  Colin Powell
  59. “There is more to life than increasing its speed.” – Mahatma Gandhi
  60. “Your attitude is like a box of crayons that color your world. Constantly color your picture gray, and your picture will always be bleak. Try adding some bright colors to the picture by including humor, and your picture begins to lighten up.” – Allen Klein
  61. “Definiteness of purpose is the starting point of all achievement.” – W. Clement Stone
  62. “Success usually comes to those who are too busy to be looking for it.” – Henry David Thoreau
  63. “In matters of truth and justice, there is no difference between large and small problems, for issues concerning the treatment of people are all the same.” – Albert Einstein
  64. “Life is too short for long-term grudges.” – Elon Musk
  65. There cannot be a crisis next week. My schedule is already full.” – Henry Kissinger
  66. “Success consists of getting up just one more time than you fall.” – Oliver Goldsmith
  67. “The Earth is the cradle of humanity, but mankind cannot stay in the cradle forever.” – Konstantin Tsiolkovsky
  68. “Ours is a world of nuclear giants and ethical infants. We know more about war that we know about peace, more about killing that we know about living.” – Omar N. Bradley
  69. “Beauty surrounds us, but usually we need to be walking in a garden to know it.” – Rumi
  70. “But man is not made for defeat. A man can be destroyed but not defeated.” – Ernest Hemingway
  71. “Don’t watch the clock; do what it does. Keep going.” – Sam Levenson
  72. “Let there be work, bread, water and salt for all.” – Nelson Mandela
  73. “The social object of skilled investment should be to defeat the dark forces of time and ignorance which envelope our future.” – John Maynard Keynes
  74. “A successful society is characterized by a rising living standard for its population, increasing investment in factories and basic infrastructure, and the generation of additional surplus, which is invested in generating new discoveries in science and technology.” – Robert Trout
  75. “I know not with what weapons World War III will be fought, but World War IV will be fought with sticks and stones.” – Albert Einstein
  76. “It is the fight alone that pleases us, not the victory.” – Blaise Pascal
  77. “If you can’t describe what you are doing as a process, you don’t know what you’re doing.” – W. Edwards Deming
  78. “Never interrupt your enemy when he is making a mistake.” – Napoleon Bonaparte
  79. “Be sure you put your feet in the right place, then stand firm.” – Abraham Lincoln
  80. “Without investment there will not be growth, and without growth there will not be employment.” – Muhtar Kent
  81. “You have to do your own growing no matter how tall your grandfather was.” – Abraham Lincoln
  82. “Victory has a thousand fathers, but defeat is an orphan.” – John F. Kennedy
  83. “Delete the negative; accentuate the positive!” – Donna Karan
  84. “It’s crazy how fast time flies and how things progress.” – Nathan Chen
  85. “The world is a dangerous place to live; not because of the people who are evil, but because of the people who don’t do anything about it.” – Albert Einstein
  86. “Life isn’t about finding yourself. Life is about creating yourself.” – George Bernard Shaw
  87. “Everything has beauty, but not everyone sees it.” – Confucius
  88. A man must be big enough to admit his mistakes, smart enough to profit from them, and strong enough to correct them.” – John C. Maxwell
  89. “Walking with a friend in the dark is better than walking alone in the light.” – Helen Keller
  90. “A man who dares to waste one hour of time has not discovered the value of life.” – Charles Darwin
  91. “The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark.” – Michelangelo
  92. “Progress is man’s ability to complicate simplicity.” – Thor Heyerdahl
  93. “I like to encourage people to realize that any action is a good action if it’s proactive and there is positive intent behind it.” – Michael J. Fox
  94. “Nothing is impossible, the word itself says ‘I’m possible’!” – Audrey Hepburn
  95. “But investment in space stimulates society, it stimulates it economically, it stimulates it intellectually, and it gives us all passion.” – Bill Nye
  96. “Bitcoin, in the short or even long term, may turn out be a good investment in the same way that anything that is rare can be considered valuable. Like baseball cards. Or a Picasso.” – Andrew Ross Sorkin
  97. “Life is a tragedy when seen in close-up, but a comedy in long-shot.” – Charlie Chaplin
  98. “No matter what you’re going through, there’s a light at the end of the tunnel and it may seem hard to get to it but you can do it and just keep working towards it and you’ll find the positive side of things.” – Demi Lovato
  99. “Infrastructure investment in science is an investment in jobs, in health, in economic growth and environmental solutions.” – Oren Etzioni
  100. “Educating our children and giving them the skills they need to compete in a global economy is a smart investment in our country’s future.” – Sheldon Whitehouse
  101. “Know thy self, know thy enemy. A thousand battles, a thousand victories.” – Sun Tzu
  102. “If one does not know to which port one is sailing, no wind is favorable.” – Lucius Annaeus Seneca
  103. “Beware of missing chances; otherwise it may be altogether too late some day.” – Franz Liszt
  104. “The sofa is a really important investment for anybody, and I don’t mean financially. You need to find a really great sofa that can transition with you, and you can build from there.” – Jeremiah Brent
  105. “There is no investment you can make which will pay you so well as the effort to scatter sunshine and good cheer through your establishment.” – Orison Swett Marden
  106. “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” – Marie Curie
  107. “There is little that can withstand a man who can conquer himself.” – Louis XIV
  108. “In tennis, you strike a ball just after the rebound for the fastest return. It’s the same with investment.” – Masayoshi Son
  109. “A camel makes an elephant feel like a jet plane.” – Jackie Kennedy
  110. “The advance of technology is based on making it fit in so that you don’t really even notice it, so it’s part of everyday life.” – Bill Gates
  111. “Success depends upon previous preparation, and without such preparation there is sure to be failure.” – Confucius, Chinese 
  112. “Coming together is a beginning; keeping together is progress; working together is success.” – Edward Everett Hale
  113. “Never do anything against conscience even if the state demands it.”– Albert Einstein
  114. “Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey
  115. “The true measure of a man is how he treats someone who can do him absolutely no good.” – Samuel Johnson
  116. “In my view, the biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. Not only is the mere drop in stock prices not risk, but it is an opportunity. Where else do you look for cheap stocks?” – Li Lu
  117. “A successful society is characterized by a rising living standard for its population, increasing investment in factories and basic infrastructure, and the generation of additional surplus, which is invested in generating new discoveries in science and technology.” – Robert Trout
  118. “The best preparation for tomorrow is doing your best today.” – H. Jackson Brown, Jr.
  119. “Friendship marks a life even more deeply than love. Love risks degenerating into obsession, friendship is never anything but sharing.” – Elie Wiesel
  120. “Investing in women’s lives is an investment in sustainable development, in human rights, in future generations – and consequently in our own long-term national interests.” – Liya Kebede
  121. “Success isn’t measured by money or power or social rank. Success is measured by your discipline and inner peace.” – Mike Ditka
  122. “No matter how many goals you have achieved, you must set your sights on a higher one.” – Jessica Savitch 
  123. “Start where you are. Use what you have. Do what you can.”– Arthur Ashe
  124. “The secret of getting ahead is getting started.” – Mark Twain
  125. “The amount of work and the amount of both physical and emotional investment it takes to get to the top.” – Drew Bledsoe

Videos